Csam Health Group AS
OSE:CSAM
Intrinsic Value
CSAM Health Group AS is an e-health software company, which engages in the provision of clinical solutions for hospitals. [ Read More ]
The intrinsic value of one
CSAM
stock under the Base Case scenario is
26.8
NOK.
Compared to the current market price of 39.8 NOK,
Csam Health Group AS
is
Overvalued by 33%.
Csam Health Group AS's market capitalization is 830.7m NOK.
CSAM stock price is 39.8 NOK.
CSAM stock (26.8 NOK) is 33% less than its price (39.8 NOK).
CSAM stock price (39.8 NOK) is 25% less than its Relative Value (53.07 NOK). Open Relative Valuation
CSAM has upside potential of 47% compared to the average analyst price target.
Open Wall St Estimates
CSAM's long-term liabilties (680m NOK) exceed its long-term assets (679m NOK).
CSAM's Revenue has grown by 8% over the past 12 months.
CSAM's Revenue has been growing by 12% per year for the last 3 years.
CSAM's short-term assets (273m NOK) exceed its short-term liabilties (158m NOK).
CSAM's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 3% to -15%.
CSAM has positive Net Debt. This means that the company has more debt (496m NOK) than cash and short-term investments (182m NOK).
CSAM has negative Free Cash Flow for the last twelve months.
CSAM's ROE (Return on Equity) has significantly decreased in the last 3 years from -6% to -200%, and is approaching profitability.
CSAM's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -15%.
CSAM has negative Operating Income for the last twelve months.
CSAM has negative Net Income for the last twelve months.
CSAM's ROE (Return on Equity) for the past 12 months is negative and is equal to -200%.
CSAM has negative three-year average ROIC (Return on Invested Capital): -7%. The company is not efficient at using invested capital to generate operating income.
CSAM has positive Gross Profit for the last twelve months.
CSAM's Altman Z-Score is very low and is equal to 0.84.
CSAM has negative three-year average ROE (Return on Equity): -65%. The company is not efficient at transforming stockholders' equity into net income.
CSAM's D/E (Debt to Equity) is very low and is equal to -686.93.
Valuation Backtest
Csam Health Group AS
Run backtest to discover the historical profit from buying and selling
CSAM
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Csam Health Group AS
Balance Sheet Decomposition
Csam Health Group AS
| Current Assets | 272.6m |
| Cash & Short-Term Investments | 182.4m |
| Receivables | 90.1m |
| Other Current Assets | 26k |
| Non-Current Assets | 406.5m |
| PP&E | 8.5m |
| Intangibles | 367.7m |
| Other Non-Current Assets | 30.3m |
| Current Liabilities | 158.1m |
| Accounts Payable | 10.5m |
| Other Current Liabilities | 147.6m |
| Non-Current Liabilities | 521.7m |
| Long-Term Debt | 496m |
| Other Non-Current Liabilities | 25.7m |
Earnings Waterfall
Csam Health Group AS
|
Revenue
|
388.8m
NOK
|
|
Cost of Revenue
|
-34.7m
NOK
|
|
Gross Profit
|
354.1m
NOK
|
|
Operating Expenses
|
-431.4m
NOK
|
|
Operating Income
|
-77.2m
NOK
|
|
Other Expenses
|
-29.7m
NOK
|
|
Net Income
|
-106.9m
NOK
|
Free Cash Flow Analysis
Csam Health Group AS
CSAM Profitability Score
Profitability Due Diligence
Csam Health Group AS's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
Score
Csam Health Group AS's profitability score is 28/100. The higher the profitability score, the more profitable the company is.
CSAM Solvency Score
Solvency Due Diligence
Csam Health Group AS's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Score
Csam Health Group AS's solvency score is 50/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CSAM Price Targets Summary
Csam Health Group AS
According to Wall Street analysts, the average 1-year price target for
CSAM
is 58.5 NOK
.
Shareholder Return
CSAM Price
Csam Health Group AS
| Average Annual Return | 3.12% |
| Standard Deviation of Annual Returns | 28% |
| Max Drawdown | -74% |
| Market Capitalization | 830.7m NOK |
| Shares Outstanding | 20 916 733 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Csam Health Group AS
Country
Industry
Market Cap
Dividend Yield
Description
CSAM Health Group AS is an e-health software company, which engages in the provision of clinical solutions for hospitals. The company is headquartered in Oslo, Oslo. The company went IPO on 2020-10-09. Its specialized software solutions are instrumental in the clinical care processes of healthcare providers and in enabling emergency responders to enhance public safety. The Company’s product portfolio includes solutions in public safety, connected healthcare, women and children's health, laboratory information management systems, medical imaging, medication management, and health analytics. CSAM is headquartered in Oslo, Norway with local offices in Sweden, Denmark, Finland, UK, Lithuania, Spain, New Zealand, the United States and the Philippines. CSAM delivers software and services to almost all hospitals in the Nordic region.
Officers
The intrinsic value of one
CSAM
stock under the Base Case scenario is
26.8
NOK.
Compared to the current market price of 39.8 NOK,
Csam Health Group AS
is
Overvalued by 33%.
You don't have any saved screeners yet
